Janux Therapeutics, Inc. (JANX) Net income 2020–2025
Janux Therapeutics, Inc. (JANX) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$113.6MFY2025 · since FY2020: -$6.8M → -$113.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$113.6M | -64.7% |
| FY2024 | -$69.0M | -18.4% |
| FY2023 | -$58.3M | +7.6% |
| FY2022 | -$63.1M | -93.0% |
| FY2021 | -$32.7M | -381.6% |
| FY2020 | -$6.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice